DRUG-INDUCED LIVER INJURY ASSOCIATED WITH SKIN HYPERSENSITIVITY REACTIONS

Anggun Putri Yuniaswan, Nadia Aprilia Fitriana

Abstract


Drug-induced liver injury (DILI) is a liver injury that is often caused by drugs that cause liver dysfunction. Drug-Induced Hypersensitivity Syndrome (DIHS) is a severe drug reaction with skin and systemic manifestations. Anti-epileptic drugs, allopurinol, sulfonamides, antibiotics, and nevirapine are the top five drugs responsible for DILI-related DIHS. The incidence of DILI at RSUD Dr. Saiful Anwar Malang in 2013 reached 5.4%. A case was reported in 19 years-old woman came with complaints of red rashes throughout the body accompanied by fever and itching 3 days before being hospitalized. The patient was diagnosed with Meningitis and Pulmonary Tuberculosis since two months before hospitalized. Symptoms appeared after the patient took TB drugs and phenytoin for three weeks. Laboratory tests showed eosinophilia, transaminitis, hyperbilirubinemia, with Regiscar score 5 (probable DRESS). Since then, TB drugs and phenytoin have been stopped then the patient received Levofloxacin, Levetiracetam, Corticosteroid, N-acetylcysteine, and Curcuma. The signs and symptoms improved in 13 days of follow-up. DILI-related hypersensitivity reactions must be managed appropriately to prevent irreversible liver damage. The cause of DILI in this case, couldn’t be ruled out, but TB drugs and phenytoin often trigger hypersensitivity reactions.

Keywords


DILI, DIHS, phenytoin, OAT

Full Text:

PDF

References


Wu Y, Xiao G, Zong P, Jiang G, Liao

Y, Liu Z, Zhou Y. Diagnosis of

Hypersensitivity Induced by

Antituberculosis Drugs. Journal of

Healthcare Engineering. 2021 Dec

;2021.

Shin HJ, Chang JS, Kim MS, Koh

BG, Park HY, Kim TO, Park CK, Oh

IJ, Kim YI, Lim SC, Kim YC.

Hypersensitivity reactions to multiple

anti-tuberculosis drugs. Plos one.

Feb 4;16(2):e0246291.

Menteri Kesehatan Republik

Indonesia. Pedoman Nasional

Pelayanan Kedokteran Tata

Laksana Tuberkulosis [Internet].

Jakarta; 2020. p 1–156. Available

from: http://journal.umsurabaya.ac.id/index.php/JKM/articl

e/view/2203

World Health Organization. WHO

consolidated guidelines on

tuberculosis. Module 4: treatmentdrug-susceptible tuberculosis

treatment. World Health

Organization; 2022 Apr 30. p 98.

Pichler WJ. Immune

pathomechanism and classification

of drug hypersensitivity. Allergy.

Aug;74(8):1457-71.

Shiohara T, Mizukawa Y. Druginduced hypersensitivity syndrome

(DiHS)/drug reaction with

eosinophilia and systemic symptoms

(DRESS): An update in 2019.

Allergology International.

;68(3):301-8. Available from:

https://doi.org/10.1016/j.alit.2019.03.

Moreno-Torres M, Quintás G, Castell

JV. The potential role of

metabolomics in drug-induced liver

injury (DILI) assessment.

Metabolites. 2022 Jun 19;12(6):564.

Chughlay MF, Blockman M, Cohen

K. A clinical approach to druginduced liver injury. Current allergy &

clinical immunology. 2015 Dec

;28(4):252-6.

Devarbhavi H, Raj S. Drug‐induced

liver injury with skin reactions: Drugs

and host risk factors, clinical

phenotypes and prognosis. Liver

International. 2019 May;39(5):802-

Yokoi T, Oda S. Models of

idiosyncratic drug-induced liver

injury. Annual Review of

Pharmacology and Toxicology. 2021

Jan 6;61:247-68.

Heelan K, Sibbald C, Shera NH.

Cutaneous Reactions to Drugs. In:

Kang S, Amagai M, Bruckner AL,

Enk AH, Margolis DJ, McMichael AJ,

et al., editors. Fitzpatrick’s

Dermatology. 9th ed. New York:

McGraw-Hill Education; 2019. p.

–36.

Novita I, Mahmuda N, Adrian M,

Putra S, Universitas FK, Surakarta

M, et al. Reaksi Alergi Obat Pada

Pasien Tuberculosis Paru Dengan

Gambaran Radiologi Menyerupai

Pancoast Tumor ; Tantangan

Diagnosis Dan Terapi. 2020: 199–


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.